Literature DB >> 15102090

Molecular size as the main determinant of solute maximum flux across the skin.

Beatrice M Magnusson1, Yuri G Anissimov, Sheree E Cross, Michael S Roberts.   

Abstract

One of the most important determinants of dermatological and systemic penetration after topical application is the delivery or flux of solutes into or through the skin. The maximum dose of solute able to be delivered over a given period of time and area of application is defined by its maximum flux (J(max), mol per cm(2) per h) from a given vehicle. In this work, J(max) values from aqueous solution across human skin were acquired or estimated from experimental data and correlated with solute physicochemical properties. Whereas epidermal permeability coefficients (k(p)) are optimally correlated to solute octanol-water partition coefficient (K(ow)) and molecular weight (MW) was found to be the dominant determinant of J(max) for this literature data set: log J(max)=-3.90-0.0190MW (n=87, r(2)=0.847, p<0.001). Estimated solubility in octanol (S(oc)) was also a determinant, but improvement in the regression by the addition of log S(oc) was small (r(2) increased to 0.856). Addition of other physicochemical parameters to MW by forward stepwise regression only marginally improved the regression with a melting point (Mpt) term (r(2)=0.879) and then hydrogen bonding acceptor capability (H(a)) (r(2)=0.917) is significant. Validation of the equation above was carried with a number of other data sets: an aqueous vehicle with full- and split-thickness skin (r(2)=0.784, n=56), some pure solutes (r(2)=0.537, n=34), an aqueous vehicle with ionizable solutes (r(2)=0.282, n=54) and solutes from a propylene glycol vehicle (r(2)=0.484, n=36). An analysis of the entire database gave the equation log J(max)=-4.52-0.0141MW (n=278, r(2)=0.688, p<0.001), with inclusion of Mpt and H(a) increasing r(2) to 0.760 (n=269). Separate analysis of full- and split-thickness skin data confirmed that the dermal resistance term had only a marginal effect on overall J(max). Application of the latter model to an in vivo situation where the dermal capillary bed is slightly below the epidermal-dermal junction revealed that the dermal resistance term was unnecessary for in vivo predictions for most solutes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102090     DOI: 10.1111/j.0022-202X.2004.22413.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  26 in total

1.  Simple rules defining the potential of compounds for transdermal delivery or toxicity.

Authors:  Beatrice M Magnusson; W John Pugh; Michael S Roberts
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

2.  Skin solubility determines maximum transepidermal flux for similar size molecules.

Authors:  Qian Zhang; Jeffrey E Grice; Peng Li; Owen G Jepps; Guang-Ji Wang; Michael S Roberts
Journal:  Pharm Res       Date:  2009-06-05       Impact factor: 4.200

3.  Nanoparticles do not penetrate human skin--a theoretical perspective.

Authors:  Adam C Watkinson; Annette L Bunge; Jonathan Hadgraft; Majella E Lane
Journal:  Pharm Res       Date:  2013-05-31       Impact factor: 4.200

Review 4.  Transdermal patches: history, development and pharmacology.

Authors:  Michael N Pastore; Yogeshvar N Kalia; Michael Horstmann; Michael S Roberts
Journal:  Br J Pharmacol       Date:  2015-03-18       Impact factor: 8.739

5.  Nanoparticles and their interactions with the dermal barrier.

Authors:  Marc Schneider; Frank Stracke; Steffi Hansen; Ulrich F Schaefer
Journal:  Dermatoendocrinol       Date:  2009-07

6.  Human skin permeation of emerging mycotoxins (beauvericin and enniatins).

Authors:  Lien Taevernier; Lieselotte Veryser; Nathalie Roche; Kathelijne Peremans; Christian Burvenich; Catherine Delesalle; Bart De Spiegeleer
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-03-11       Impact factor: 5.563

7.  Estimation of maximum transdermal flux of nonionized xenobiotics from basic physicochemical determinants.

Authors:  Mikolaj Milewski; Audra L Stinchcomb
Journal:  Mol Pharm       Date:  2012-06-15       Impact factor: 4.939

8.  An integrated pharmacokinetic and imaging evaluation of vehicle effects on solute human epidermal flux and, retention characteristics.

Authors:  G Winckle; Y G Anissimov; S E Cross; G Wise; M S Roberts
Journal:  Pharm Res       Date:  2007-09-22       Impact factor: 4.200

9.  Effect of vehicles on the maximum transepidermal flux of similar size phenolic compounds.

Authors:  Qian Zhang; Peng Li; David Liu; Michael S Roberts
Journal:  Pharm Res       Date:  2012-08-25       Impact factor: 4.200

10.  Metabolism of fatty acids and lipid hydroperoxides in human body monitoring with Fourier transform Infrared Spectroscopy.

Authors:  Satoshi Yoshida; Qin-Zeng Zhang; Shu Sakuyama; Satoshi Matsushima
Journal:  Lipids Health Dis       Date:  2009-07-24       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.